GlassScriptPhysician profile
Ti J Tsay
NPI 1942358742
$66,508.78
in general payments reported to CMS, 2019-2025
5 companies · $12K in 2025
The $12K reported for 2025 was more than what 99% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,085 · 2020: $2,190 · 2021: $460 · 2022: $16K · 2023: $15K · 2024: $18K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $36K · Consulting Fee: $5,375 · Food and Beverage: $3,236 · Travel and Lodging: $183 · Entertainment: $119.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $36,071.85 |
| Consulting Fee | $5,375.00 |
| Food and Beverage | $3,236.41 |
| Travel and Lodging | $183.31 |
| Entertainment | $119.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $58,165.27 | 2019-2025 | Dysport |
| Musculoskeletal Transplant Foundation INC. | $4,541.98 | 2019-2025 | |
| Abbvie INC. | $2,032.38 | 2023-2025 | Botox |
| Allergan, INC. | $1,741.38 | 2019-2022 | |
| Merz North America, INC. | $27.77 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ti Tsay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.